Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy

被引：0
|
作者：
Cristina Chiriaco
Chiara Donini
Marco Cortese
Stefano Ughetto
Chiara Modica
Ilaria Martinelli
Alessia Proment
Letizia Vitali
Lara Fontani
Monica Casucci
Paolo Maria Comoglio
Silvia Giordano
Dario Sangiolo
Valeria Leuci
Elisa Vigna
机构：
[1] Candiolo Cancer Institute,Department of Oncology
[2] FPO-IRCCS,Present address: Department of Surgical, Oncological and Stomatological Sciences (DICHIRONS)
[3] University of Turin,Innovative Immunotherapies Unit
[4] Present address: Bios-Therapy,undefined
[5] Physiological System for Health S.p.A,undefined
[6] University of Palermo,undefined
[7] IRCCS San Raffaele Scientific Institute,undefined
[8] IFOM-FIRC Institute of Molecular Oncology,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 41卷
关键词：
MET oncogene; Immunotherapy; CAR; Targeted therapy; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
    Miao, Lele
    Zhang, Zhengchao
    Ren, Zhijian
    Tang, Futian
    Li, Yumin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [42] TUMOR TARGETED SUPERANTIGEN (TTS), NAPTUMOMAB ESTAFENATOX (NAP), ENHANCES CAR-T CELLS POTENCY AND CAN BOOST CAR-T EFFICACY AGAINST SOLID TUMORS
    Sagi, Yael
    Shahar, Michal
    Pinsker, Marina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A605 - A605
  • [43] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Chohan, Karan L.
    Siegler, Elizabeth L.
    Kenderian, Saad S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (02) : 9 - 18
  • [44] Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors
    Hirobe, Sachiko
    Nagai, Seina
    Tachibana, Masashi
    Okada, Naoki
    BIOMEDICINES, 2022, 10 (06)
  • [45] Impacts of ageing on the efficacy of CAR-T cell therapy
    Qi, Shimao
    Li, Jiaqian
    Gu, Xinyu
    Zhang, Yalan
    Zhou, Weilin
    Wang, Fengling
    Wang, Wei
    AGEING RESEARCH REVIEWS, 2025, 107
  • [46] Efficacy and safety of CAR-T cell therapy in minorities
    Thakkar, Astha
    Abreu, Michelly
    Pradhan, Kith
    Sica, R. Alejandro
    Shastri, Aditi
    Kornblum, Noah
    Shah, Nishi
    Mantzaris, Ioannis
    Gritsman, Kira
    Feldman, Eric
    Elkind, Richard
    Green-Lorenzen, Susan
    Verma, Amit
    Braunschweig, Ira
    Goldfinger, Mendel
    BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1187 - 1190
  • [47] Efficacy and safety of CAR-T cell therapy in minorities
    Astha Thakkar
    Michelly Abreu
    Kith Pradhan
    R. Alejandro Sica
    Aditi Shastri
    Noah Kornblum
    Nishi Shah
    Ioannis Mantzaris
    Kira Gritsman
    Eric Feldman
    Richard Elkind
    Susan Green-Lorenzen
    Amit Verma
    Ira Braunschweig
    Mendel Goldfinger
    Bone Marrow Transplantation, 2022, 57 : 1187 - 1190
  • [48] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Karan L. Chohan
    Elizabeth L. Siegler
    Saad S. Kenderian
    Current Hematologic Malignancy Reports, 2023, 18 : 9 - 18
  • [49] Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma
    Reyes, Kevin R.
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    BLOOD, 2022, 140 : 5105 - 5107
  • [50] Efficacy and safety of BCMA-targeted CAR-T therapy in elderly patients with multiple myeloma
    Reyes, Kevin
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy
    Wolf, Jeffrey
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S5 - S5
12345